tiprankstipranks
Trending News
More News >
Kane Biotech (TSE:KNE)
:KNE
Canadian Market
Advertisement

Kane Biotech (KNE) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Kane Biotech’s (KNE) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Kane Biotech is a Sell.
Kane Biotech’s (KNE) 20-Day exponential moving average is 0.04, while Kane Biotech’s (KNE) share price is <C$0.1, making it a Sell.
Kane Biotech’s (KNE) 50-Day exponential moving average is 0.05, while Kane Biotech’s (KNE) share price is <C$0.1, making it a Sell.

Kane Biotech (KNE) Pivot Points

Aug 14, 2025, 02:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.03
0.04
0.04
0.04
0.04
0.05
Fibonacci
0.03
0.04
0.04
0.04
0.04
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kane Biotech (KNE) Moving Averages

Aug 14, 2025, 02:59 AM
Period
Simple
Exponential
MA5
0.04Buy
0.04Sell
MA10
0.04Sell
0.04Sell
MA20
0.04Buy
0.04Sell
MA50
0.05Sell
0.05Sell
MA100
0.07Sell
0.06Sell
MA200
0.09Sell
0.08Sell
Kane Biotech’s (KNE) 10-Day exponential moving average is 0.04, while Kane Biotech’s (KNE) share price is <C$0.1, making it a Sell.
Kane Biotech’s (KNE) 100-Day exponential moving average is 0.06, while Kane Biotech’s (KNE) share price is <C$0.1, making it a Sell.
Kane Biotech’s (KNE) stock price is <C$0.1 and Kane Biotech’s (KNE) 50-day simple moving average is 0.05, creating a Sell signal.
Kane Biotech’s (KNE) stock price is <C$0.1 and Kane Biotech’s (KNE) 100-day simple moving average is 0.07, creating a Sell signal.
Kane Biotech’s (KNE) stock price is <C$0.1 and Kane Biotech’s (KNE) 200-day simple moving average is 0.09, creating a Sell signal.

Kane Biotech (KNE) Technical Indicators

Aug 14, 2025, 02:59 AM
Name
Value
Implied Action
RSI (14)
40.08
Neutral
STOCH (9,6)
50.00
Neutral
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
52.36
Sell
Williams %R
-50.00
Buy
CCI (14)
-13.54
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
53.15
Neutral
ROC
0.00
Sell
Kane Biotech’s (KNE) Relative Strength Index (RSI) is 40.08, creating a Neutral signal.
Kane Biotech’s (KNE) Trend Strength Indicator (ADX) is 52.36, creating a Sell signal.
Kane Biotech’s (KNE) Commodity Channel Index (CCI) is -13.54, creating a Neutral signal.

FAQ

Is KNE a Buy, Hold, or Sell?
Based on KNE’s technical indicators, KNE is a Sell.
    What is KNE’s RSI (14)?
    KNE’s RSI (14) is 40.08, which suggests KNE is a Neutral.
      What is KNE’s MACD?
      KNE’s MACD is >-0.01, which suggests KNE is a Sell.
        What is KNE’s 5-day moving average?
        KNE’s 5-day moving average is 0.04, which suggests KNE is a Buy.
          What is KNE’s 20-day moving average?
          KNE 20-day moving average is 0.04, which suggests KNE is a Buy.
            What is KNE’s 50-day moving average?
            KNE’s 50-day moving average is 0.05, which suggests KNE is a Sell.
              What is KNE’s 200-day moving average?
              KNE’s 200-day moving average is 0.09, which suggests KNE is a Sell.
                What is KNE’s Williams % R (14)?
                KNE’s Williams % R (14) is -50.00, which suggests KNE is a Buy.
                  What is KNE’s CCI (14)?
                  KNE’s CCI (14) is -13.54, which suggests KNE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis